Filing Flows › Comparisons › INBS vs RNXT
Intelligent Bio Solutions vs RenovoRx: INBS and RNXT compared
Intelligent Bio Solutions is the larger company: $1.1M of revenue in its latest quarter (Q4 FY26) against $1.1M for RenovoRx (Q3 2026). RenovoRx is growing faster (+301% against +36% a year earlier). RenovoRx is more profitable, with an operating margin of -303.6% against -346.4%.
Where the money goes: INBS and RNXT
Intelligent Bio Solutions (INBS) · Q4 FY26
Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%, net loss $3.9M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.
RenovoRx (RNXT) · Q3 2026
RenovoRx, Q3 2026: revenue $1.1M (+301% year over year), operating margin -303.6%, net loss $3.6M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Intelligent Bio Solutions (INBS) | RenovoRx (RNXT) | |
|---|---|---|
| Latest quarter | Q4 FY26 | Q3 2026 |
| Revenue | $1.1M | $1.1M |
| Revenue growth, Y/Y | +36% | +301% |
| Operating margin | -346.4% | -303.6% |
| Net earnings | −$3.9M | −$3.6M |
| Net margin | -341.9% | -342.1% |
| Operating cash flow | −$3.2M | −$2.5M |
Where the revenue comes from
Intelligent Bio Solutions
- Sales of Goods - Cartidges: $625K (55%)
- Other sales - accessories: $291K (25%)
- Sales of Goods - Readers: $229K (20%)
Questions
Which is bigger, Intelligent Bio Solutions or RenovoRx?
Intelligent Bio Solutions is the larger company: $1.1M of revenue in its latest quarter (Q4 FY26) against $1.1M for RenovoRx (Q3 2026).
Is Intelligent Bio Solutions or RenovoRx growing faster?
RenovoRx is growing faster (+301% against +36% a year earlier).
Which is more profitable, Intelligent Bio Solutions or RenovoRx?
RenovoRx is more profitable, with an operating margin of -303.6% against -346.4%.
More: Intelligent Bio Solutions earnings · how Intelligent Bio Solutions makes money · RenovoRx earnings · how RenovoRx makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Aug 19, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.